5 hrs ago
BioTime's CEO, Dr. Michael West to Take Part in the 2013 World Stem Cell Summit
In addition to Dr. West, Dr. Israeli subsidiary LifeMap Sciences, will give a presentation titled "LifeMap Discovery: An online database, integrating molecular and cellular information on embryonic development to improve stem cell research."
LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards Version 3.11
The new release is available at www.genecards.org . GeneCards A is a comprehensive online database that provides comprehensive information on all human genes.
BioTime's CEO, Dr. Michael West to Moderate Session on Mapping...
The session will include world leaders in stem cell biology discussing how major advances in stem cell science and human health could be achieved by databasing the cellular components of the human body.
BioTime CEO Dr. Michael West to Present at 11th Annual Commercial...
BioTime, Inc. , a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, PhD will present at the 11th Annual Commercial Translation of Regenerative Medicine conference in London on Monday, November 25, 2013.
BioTime Announces Third Quarter 2013 Financial Results and Recent Corporate Accomplishments
BioTime, Inc. , a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the third quarter ended September 30, 2013 and highlighted recent corporate accomplishments.